Donate
Email Password
Not a member? Sign Up   Forgot password?
Business and Economics Education Environment Health Care California
Home
About PRI
My PRI
Contact
Search
Policy Research Areas
Events
Publications
Press Room
PRI Blog
Jobs Internships
Scholars
Staff
Book Store
Policy Cast
Upcoming Events
WSJ's Stephen Moore Book Signing Luncheon-Rescheduled for December 17
12.17.2012 12:00:00 PM
Who's the Fairest of Them All?: The Truth About Opportunity, ... 
More

Recent Events
Victor Davis Hanson Orange County Luncheon December 5, 2012
12.5.2012 12:00:00 PM

Post Election: A Roadmap for America's Future

 More

Post Election Analysis with George F. Will & Special Award Presentation to Sal Khan of the Khan Academy
11.9.2012 6:00:00 PM

Pacific Research Institute Annual Gala Dinner

 More

Reading Law: The Interpretation of Legal Texts
10.19.2012 5:00:00 PM
Author Book Signing and Reception with U.S. Supreme Court Justice ... More

Opinion Journal Federation
Town Hall silver partner
Lawsuit abuse victims project
Blog RSS Archive
E-mail Print PhRMA Is Shocked About GosHealth


By: Benjamin Zycher, Ph.D
11.9.2009

Make that shocked, shocked. "We are disappointed . . . by today's vote," PhRMA said in a statement following Saturday's House health-care vote. "While well intentioned [!], the bill . . . would have the unintended consequences [sic] of killing tens of thousands of jobs in our industry . . ."

As I have argued before, it just doesn't get any stupider than this. Having made an unenforceable $80 billion deal with the White House, having spent upwards of $130 million on advertising in favor of health-care socialism, having been blind all this time to the reality that they are in an ideological battle in which the Left has painted a bullseye on them: PhRMA now just cannot believe that the Beltway Left would view them as both a piggy bank and an obstacle blocking their fundamental goal of centralizing health care, health-care research, and health-care lobbying in the vast monster soon to be known as GosHealth.

 

Benjamin Zycher

The comedy highlight, of course, is the plaintive cry about "killing tens of thousands of jobs in our industry." Did PhRMA believe that the $80 billion deal would have increased such employment? Did it not occur to them that the $80 billion inevitably would come to be an opening bid? Does PhRMA believe that the Pelosi/Waxman axis gives a hoot about PhRMA employment? Does PhRMA believe that Mr. Obama would veto a bill violating his earlier promises? This utter unreality is really quite amazing. But not as amazing as the salaries these guys are paid to pursue their own destruction, and ours.

The comedy highlight, of course, is the plaintive cry about "killing tens of thousands of jobs in our industry." Did PhRMA believe that the $80 billion deal would have increased such employment? Did it not occur to them that the $80 billion inevitably would come to be an opening bid? Does PhRMA believe that the Pelosi/Waxman axis gives a hoot about PhRMA employment? Does PhRMA believe that Mr. Obama would veto a bill violating his earlier promises? This utter unreality is really quite amazing. But not as amazing as the salaries these guys are paid to pursue their own destruction, and ours.

Benjamin Zycher is a senior fellow at the Pacific Research Institute.



This blog post originally appeared on National Review's Critical Condition.

 




 

Submit to: 
Submit to: Digg Submit to: Del.icio.us Submit to: Facebook Submit to: StumbleUpon Submit to: Newsvine Submit to: Reddit
Browse by
Recent Publications
Blog Archive
Powered by eResources